Detalhe da pesquisa
1.
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
Haematologica;
108(10): 2730-2742, 2023 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37165840
2.
Molecular classification of hormone-sensitive and castration-resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens.
Prostate;
82(9): 993-1002, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35435276
3.
Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome.
Am J Kidney Dis;
79(6): 807-819.e1, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34864148
4.
A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project.
Physiol Genomics;
53(1): 1-11, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33197228
5.
Systems biology approaches to identify disease mechanisms and facilitate targeted therapy in the management of glomerular disease.
Curr Opin Nephrol Hypertens;
27(6): 433-439, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30074515
6.
An integrative systems biology approach for precision medicine in diabetic kidney disease.
Diabetes Obes Metab;
20 Suppl 3: 6-13, 2018 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30294956
7.
Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.
J Biol Chem;
290(9): 5566-81, 2015 Feb 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25468909
8.
Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures.
Gynecol Oncol;
141(1): 95-100, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27016234
9.
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.
Hum Mol Genet;
22(15): 3038-47, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23571109
10.
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
Clin Lymphoma Myeloma Leuk;
24(6): 364-374, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38378362
11.
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade.
Cancer Cell;
42(3): 429-443.e4, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38366589
12.
Tetramer-aided sorting and single-cell RNA sequencing facilitate transcriptional profiling of antigen-specific CD8+ T cells.
Transl Oncol;
27: 101559, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36279715
13.
Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM.
Front Immunol;
14: 1085893, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37559718
14.
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk;
23(1): e59-e70, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36450626
15.
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial.
Clin Cancer Res;
29(9): 1698-1707, 2023 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36595569
16.
CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy.
Cell Rep Med;
4(1): 100878, 2023 01 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36599350
17.
Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling.
Front Oncol;
12: 948548, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36033464
18.
A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia.
Leuk Lymphoma;
63(5): 1058-1069, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35045765
19.
Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma.
JAMA Oncol;
8(2): 275-280, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34940781
20.
Systems Biology and Kidney Disease.
Clin J Am Soc Nephrol;
15(5): 695-703, 2020 05 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31992571